Efficacy of tnf-α gene-transduced tumor cells in treatment of establishedin vivo tumor
- 27 September 1995
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 63 (1), 130-135
- https://doi.org/10.1002/ijc.2910630123
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Augmented Systemic Immunity in Mice Implanted with Tumor Necrosis Factor‐α Gene‐transduced Meth‐A CellsJapanese Journal of Cancer Research, 1994
- Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.The Journal of Experimental Medicine, 1993
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.The Journal of Experimental Medicine, 1991
- Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.The Journal of Experimental Medicine, 1991
- Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.The Journal of Experimental Medicine, 1990
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2.Proceedings of the National Academy of Sciences, 1988
- Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.Proceedings of the National Academy of Sciences, 1988
- Expression of human class II major histocompatibility complex antigens using retrovirus vectors.Proceedings of the National Academy of Sciences, 1987